FROST PHILLIP MD ET AL

13D and 13G Filings

13D/G filings
13D on 4 securities, 13G on 2 securities
CIK
0000898860
All SEC filings
View on sec.gov
Issuer % of Class Filed
Safe Pro Group Inc. 13G
SPAI · 78642D101
9.8% 9/14/2026
Event 9/9/2026
Cocrystal Pharma, Inc. 13D/A Amendment 8
COCP · 19188J409
13.9% 8/7/2026
Event 8/3/2026
Opko Health, Inc. 13D/A Amendment 28
OPK · 68375N103
34.1% 7/1/2026
Event 6/29/2026
Fluent, Inc. 13D/A Amendment 27
FLNT · 34380C201
24.7% 1/28/2026
Event 12/22/2025
Cocrystal Pharma, Inc. 13D/A Amendment 7
COCP · 19188J409
17.8% 10/30/2025
Event 10/28/2025
Cocrystal Pharma, Inc. 13D/A Amendment 6
COCP · 19188J409
10.6% 10/2/2025
Event 9/30/2025
Opko Health, Inc. 13D/A Amendment 27
OPK · 68375N103
32.8% 10/1/2025
Event 9/30/2025
Fluent, Inc. 13D/A Amendment 26
FLNT · 34380C201
28.3% 8/26/2025
Event 8/19/2025
Nocopi Technologies Inc/MD/ 13D/A Amendment 1
NNUP · 655213106
13.6% 6/11/2025
Event 6/6/2025
Fluent, Inc. 13D/A Amendment 25
FLNT · 34380C201
31.1% 5/23/2025
Event 5/19/2025
Opko Health, Inc. 13D/A Amendment 26
OPK · 68375N103
31.7% 4/3/2025
Event 4/2/2025
Fluent, Inc. 13D/A Amendment 24
FLNT · 34380C201
23.7% 4/2/2025
Event 3/20/2025
Douglas Elliman Inc. 13G/A Amendment 2
DOUG · 25961D105
8.6% 2/11/2025
Event 1/1/2025

Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.